Donald W. Landry

Q: What Schools Are Affiliated With Donald W. Landry

Donald W. Landry is affiliated with the following schools: Albert Einstein College of Medicine, Columbia University

Donald W. Landry's AcademicInfluence.com Rankings

Donald W. Landry

Philosophy

#9642

World Rank

#13231

Historical Rank

Logic

#6612

World Rank

#8145

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Donald W. Landry's Degrees

Doctorate Medicine Columbia University
PhD Biomedical Engineering Columbia University

Why Is Donald W. Landry Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald W. Landry's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Post-acute COVID-19 syndrome (2021) (2173)
Extrapulmonary manifestations of COVID-19 (2020) (1998)
The pathogenesis of vasodilatory shock. (2001) (1002)
Aptamer-based folding fluorescent sensor for cocaine. (2001) (602)
Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2 (2004) (478)
Vasopressin deficiency contributes to the vasodilation of septic shock. (1997) (453)
Vasopressin pressor hypersensitivity in vasodilatory septic shock. (1997) (386)
The Ngal Reporter Mouse Detects the Response of the Kidney to Injury in Real Time (2010) (376)
Low-dose vasopressin in the treatment of vasodilatory septic shock. (1999) (362)
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. (1998) (360)
Fluorescent Sensors Based on Aptamer Self-Assembly. (2000) (347)
Science Review: Vasopressin and the cardiovascular system part 1 – receptor physiology (2003) (340)
Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak (2004) (339)
Aptamer-based colorimetric probe for cocaine. (2002) (303)
Remodeling of ryanodine receptor complex causes “leaky” channels: A molecular mechanism for decreased exercise capacity (2008) (296)
Iron Traffics in Circulation Bound to a Siderocalin (Ngal)-Catechol Complex (2010) (280)
Phosphodiesterase 5 Inhibition Improves Synaptic Function, Memory, and Amyloid-β Load in an Alzheimer's Disease Mouse Model (2009) (261)
Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. (1999) (234)
A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. (1997) (233)
The ATP-sensitive K+ channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. (1992) (230)
Antibody-catalyzed degradation of cocaine. (1993) (214)
Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. (1999) (214)
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study (2020) (212)
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19 (2020) (201)
Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology (2003) (189)
Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. (2000) (165)
Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. (1999) (159)
Epithelial chloride channel. Development of inhibitory ligands (1987) (138)
Molecular cloning and characterization of p64, a chloride channel protein from kidney microsomes. (1993) (136)
Embryonic death and the creation of human embryonic stem cells. (2004) (122)
Experience with right ventricular assist devices for perioperative right-sided circulatory failure. (1996) (121)
A catalytic antibody against cocaine prevents cocaine's reinforcing and toxic effects in rats. (1998) (121)
Catalytic Molecular Beacons (2001) (114)
Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase. (2003) (113)
A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. (2003) (110)
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure (2005) (104)
Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects (2017) (99)
Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock* (2004) (92)
Sitosterol-containing Lipoproteins Trigger Free Sterol-induced Caspase-independent Death in ACAT-competent Macrophages* (2006) (84)
Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease. (2013) (84)
Thermostable Variants of Cocaine Esterase for Long-Time Protection against Cocaine Toxicity (2009) (83)
Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. (1999) (83)
Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies. (2017) (78)
Locations of the β1 transmembrane helices in the BK potassium channel (2008) (68)
Derivation of Two New Human Embryonic Stem Cell Lines from Nonviable Human Embryos (2011) (68)
A ubiquitous 64-kDa protein is a component of a chloride channel of plasma and intracellular membranes. (1992) (67)
Chloride channels of intracellular organelles and their potential role in cystic fibrosis. (1992) (67)
Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. (2005) (67)
Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. (2000) (63)
Position and Role of the BK Channel α Subunit S0 Helix Inferred from Disulfide Crosslinking (2008) (61)
Anti-Cocaine Catalytic Antibodies: A Synthetic Approach to Improved Antibody Diversity (1996) (61)
The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis* (2014) (59)
Identification of small-molecule inhibitors of the AߖABAD interaction (2006) (57)
Rapid and Robust Protection against Cocaine-Induced Lethality in Rats by the Bacterial Cocaine Esterase (2006) (56)
Attenuation of endothelin effects by a chloride channel inhibitor, indanyloxyacetic acid. (1992) (56)
Vasopressin administration facilitates fluid removal during hemodialysis. (2007) (55)
Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation (2008) (53)
Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. (2000) (52)
Vasopressin deficiency and vasodilatory state in end-stage liver disease. (2011) (50)
Structural analysis of thermostabilizing mutations of cocaine esterase. (2010) (49)
Energy Barriers for Alkaline Hydrolysis of Carboxylic Acid Esters in Aqueous Solution by Reaction Field Calculations (2000) (48)
Tetrazole-catalyzed synthesis of phosphonamidate esters (1993) (47)
Vasopressin deficiency in the syndrome of irreversible shock. (2003) (47)
Location of the β4 Transmembrane Helices in the BK Potassium Channel (2009) (44)
Cross-reactive arrays based on three-way junctions. (2003) (43)
Homogeneous assays based on deoxyribozyme catalysis. (2000) (43)
Anticocaine catalytic antibodies. (2002) (40)
Photoaffinity labeling of the epithelial sodium channel. (1986) (40)
First‐principle studies of intermolecular and intramolecular catalysis of protonated cocaine (2005) (40)
116 – Approach to the Patient with Renal Disease (2012) (40)
Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. (1998) (40)
Voluntary reciprocal altruism: a novel strategy to encourage deceased organ donation. (2006) (39)
Microfluidic aptameric affinity sensing of vasopressin for clinical diagnostic and therapeutic applications (2011) (39)
Theoretical studies of fundamental pathways for alkaline hydrolysis of carboxylic acid esters in gas phase (2000) (38)
Development of novel phosphodiesterase 5 inhibitors for the therapy of alzheimer's disease. (2020) (37)
Discovery of a novel submicromolar inhibitor of the lymphoid specific tyrosine phosphatase. (2008) (36)
Identification of a Novel 1,2,3,4-Tetrahydrobenzo[b][1,6]naphthyridine Analogue as a Potent Phosphodiesterase 5 Inhibitor with Improved Aqueous Solubility for the Treatment of Alzheimer's Disease. (2017) (35)
Immunotherapy for cocaine addiction. (1997) (34)
Silencing c-Myc Translation As a Therapeutic Strategy through Targeting PI3K Delta and CK1 Epsilon in Hematological Malignancies (2016) (33)
Inhibition of lymphoid tyrosine phosphatase by benzofuran salicylic acids. (2011) (33)
Sex-specific neurobiological actions of prophylactic (R,S)-ketamine, (2R,6R)-hydroxynorketamine, and (2S,6S)-hydroxynorketamine (2020) (31)
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. (2001) (30)
Treatment of Obese Insulin-Resistant Mice With an Allosteric MAPKAPK2/3 Inhibitor Lowers Blood Glucose and Improves Insulin Sensitivity (2015) (28)
Hypocellularity and absence of compaction as criteria for embryonic death. (2006) (26)
Anti-Cocaine Catalytic Antibodies: A Synthetic Approach to Improved Antibody Diversity. (1996) (26)
Theoretical Studies of Competing Reaction Pathways and Energy Barriers for Alkaline Ester Hydrolysis of Cocaine (2001) (26)
Disaster Response to the COVID-19 Pandemic for Patients with Kidney Disease in New York City. (2020) (26)
Discovery of potent non-urea inhibitors of soluble epoxide hydrolase. (2009) (26)
Endogenous and exogenous vasopressin in shock (2007) (25)
NONENZYMATIC HYDROLYSIS OF COCAINE VIA INTRAMOLECULAR ACID CATALYSIS (1999) (24)
Convenient preparation of N-8-quinolinyl benzenesultams as novel NF-κB inhibitors (2008) (24)
Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites. (2015) (23)
The role of catecholamines in cocaine toxicity: a model for cocaine "sudden death". (1996) (23)
Covalent modification of proteins by cocaine (2002) (22)
Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys. (2001) (22)
Crystallographic and biochemical analysis of cocaine-degrading antibody 15A10. (2004) (21)
Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase. (2012) (21)
Indanyloxyacetic acid-sensitive chloride channels from outer membranes of skeletal muscle. (1993) (20)
Synthesis of 1-thioglycosides (1995) (19)
A novel inhibitor of active protein kinase G attenuates chronic inflammatory and osteoarthritic pain (2017) (18)
Non-viable human embryos as a source of viable cells for embryonic stem cell derivation. (2009) (17)
Comparison of experimental and theoretical structures of a transition state analogue used for the induction of anti-cocaine catalytic antibodies (1997) (17)
Controlled release of anti‐cocaine catalytic antibody from biodegradable polymer microspheres (2003) (16)
Structure determination of a cocaine hydrolytic antibody from a pseudomerohedrally twinned crystal. (2002) (16)
Chloride channel blockade relaxes airway smooth muscle and potentiates relaxation by β-agonists. (2014) (16)
Identification of small-molecule inhibitors of the Abeta-ABAD interaction. (2006) (16)
Characterizing vasopressin and other vasoactive mediators released during resuscitation of trauma patients (2013) (15)
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. (2008) (15)
Blood pressure instability during hemodialysis. (2006) (14)
Purification and reconstitution of epithelial chloride channels. (1990) (14)
Novel hypoglycemic dihydropyridones serendipitously discovered from O- versus C-alkylation in the synthesis of VMAT2 antagonists. (2008) (14)
Selective V1a receptor agonist FE 202158 reverses platelet-activating factor-induced hypotension, vascular leak, impaired tissue perfusion, and mortality in rats (2008) (13)
Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device. (1995) (13)
Anti-cocaine catalytic antibodies--a novel approach to the problem of addiction. (1997) (13)
New therapeutic approaches and novel alternatives for organophosphate toxicity. (2018) (13)
Total synthesis of (±)-8S, 14-cedranediol (1983) (12)
Potassium channels and septic shock. (2006) (12)
Label-free microfluidic characterization of temperature-dependent biomolecular interactions. (2011) (12)
N-ALKOXY ANALOGUES OF 3,4,5-TRIHYDROXYPIPERIDINE (1998) (12)
Alternative strategies for the derivation of human embryonic stem cell lines and the role of dead embryos. (2009) (11)
Insights into shock. (2004) (11)
Potent inhibitors of Huntingtin protein aggregation in a cell-based assay. (2009) (11)
Patient with a sudden drop in blood pressure. (2003) (11)
San Antonio Vasopressin in Shock Symposium report. (2010) (10)
A Semiempirical Transition State Structure for the First Step in the Alkaline Hydrolysis of Cocaine. Comparison between the Transition State Structure, the Phosphonate Monoester Transition State Analog, and a Newly Designed Thiophosphonate Transition State Analog (1996) (10)
Restoration of renal function in shock by perfusion of the renal artery with venous blood: A counterintuitive approach (2002) (9)
Vasopressin and relativity: on the matter of deficiency and sensitivity. (2006) (8)
Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City. (2020) (8)
Synthesis of C-3 alkyl analogs of cocaine (2001) (6)
Substrate-assisted antibody catalysis. (2004) (6)
Natural and Artificial Enzymes Against Cocaine . I . Monoclonal Antibody 15 A 10 and the Reinforcing Effects of Cocaine in Rats 1 , 2 (2000) (6)
Discovery of novel small molecule cell type-specific enhancers of NF-kappaB nuclear translocation. (2009) (6)
GLYCOSYL PHOSPHORAMIDIMIDATES AS VERSATILE GLYCOSYL DONORS (1997) (6)
Synthesis of N-alkoxytrihydroxypiperidine analogs of allopyranose (1996) (5)
Unusual regioselectivity of dichlorocarbene addition to a norbornene derivative. X-ray structure of the stable product (1981) (5)
Position and Role of the BK Channel (cid:2) Subunit S0 Helix Inferred from Disulﬁ de Crosslinking (2008) (5)
Increased complexity of vasopressin's vascular actions (2010) (5)
Therapy for vasodilatory shock: Arginine vasopressin (2000) (5)
Anticocaine catalytic antibodies have no affinity for RTI compounds: Implications for treatment (2001) (4)
Cover Picture: Discovery of New Classes of Compounds that Reactivate Acetylcholinesterase Inhibited by Organophosphates (ChemBioChem 15/2015). (2015) (3)
Sulfhydryl-specific PEGylation of phosphotriesterase cysteine mutants for organophosphate detoxification. (2015) (3)
Ethics in Regenerative Medicine (2011) (2)
Development of First-in-Class Histone Acetyltransferase (HAT) Activators for Precision Targeting of Epigenetic Derangements in Lymphoma (2018) (2)
A microfludic aptasensor with integrated sample preconcentration, isocratic elution and mass spectrometric detection (2009) (2)
Proton pumps and chloride channels in secretory vesicles. (1989) (2)
PLASMA MEMBRANE MONOAMINE TRANSPORTER MODULATES BACE1 ACTIVITY (2016) (2)
Alternative Sources of Human Embryonic Stem Cells (2011) (2)
Tetrazole‐Catalyzed Synthesis of Phosphonate Esters. (2010) (2)
SUPPLEMENTATION OF INAPPROPRIATELY LOW ERYTHROPOIETIN LEVELS IN LVAD PATIENTS RESULTS IN DECREASED BLOOD TRANSFUSIONS (1997) (1)
Production and characterization of anti-cocaine catalytic antibodies. (2004) (1)
Renin inhibits the vasorelaxation induced by nitroso albumin. (1998) (1)
Distinct functional and conformational states of the human lymphoid tyrosine phosphatase catalytic domain can be targeted by choice of the inhibitor chemotype (2011) (1)
Chapter 4 – Vascular Tone (2006) (1)
A phase II randomized controlled trial of tiopronin for aneurysmal subarachnoid hemorrhage. (2020) (1)
TOTAL SYNTHESIS OF (.+-.)-8S,14-CEDRANEDIOL (1983) (1)
COMPARATIVE PHYSIOLOGIC EFFECTS OF VASOPRESSIN (VP), NOREPINEPHRINE (NE), AND PHENYLEPHRINE (PE) IN THE TREATMENT OF SEPTIC SHOCK (1999) (1)
Still a last step before death for thousands of people, shock is shedding some of its medical mystery and becoming more treatable (2004) (1)
P1-068 Synaptic and cognitive impairment in an amyloid-depositing mouse model after sildenafil treatment (2006) (0)
Response to |[lsquo]|Voluntary reciprocal altruism: A novel strategy to encourage decreased organ donation|[rsquo]| (2006) (0)
Strategy for Overcoming Crebbp and EP300 Mutations in Lymphoma: Development of First-in-Class HAT Activators (2019) (0)
Sa1363 Newly Synthesized Selective Beta-2 Blockers Reveal Stress Mediated Acceleration of Pancreatic Carcinogenesis (2016) (0)
Benzothiazepine derivatives as inhibitors of ryanodine receptor (RyR2) gene and their use in the treatment of heart disease (2005) (0)
N-Alkoxy Analogues of 3,4,5-Trihydroxypiperidine. (1999) (0)
Abstract of the 68th Meeting (Spring Meeting) 6–9 March 1990, Heidelberg (1990) (0)
Label-free microfluidic characterization of temperature-dependent biomolecular binding (2009) (0)
Cocaine hydrolytic antibody 15A10 (2004) (0)
Vasopressin administration facilitates fluid removal during hemodialysis. Commentary (2007) (0)
Compositions and cocaine treatment (2007) (0)
The Vocation of a Doctor * (2012) (0)
Contributors (2012) (0)
Title Silencing c-Myc translation as a therapeutic strategy through targeting PI 3 K delta and CK 1 epsilon in hematological malignancies (2016) (0)
Treatment of RAS-Mutated Multiple Myeloma by Targeting MAP4K2 (2019) (0)
V1a Agonists in Vasodilatory Shock: From Bedside to Bench, and Back (2008) (0)
16 – Purification and Reconstitution of the Epithelial Chloride Channel (1989) (0)
Agents for the prevention and treatment of disorders involving modulation of the RyR receptors (2006) (0)
Purification of the epithelial Cl channel. (1991) (0)
Sitosterol-containingLipoproteinsTriggerFreeSterol-induced Caspase-independentDeathinACAT-competentMacrophages * (2006) (0)
A process for the preparation of benzothiazepines from gamma-amino-alkylbenzenes (2009) (0)
Targeting NF-κB with First in Class N-Quinoline Benzenesulfonamides (NQBS) Reveals Potent Activity in Models of Diffuse Large B-Cell Lymphoma (DLBCL) (2015) (0)
LOW DOSE VASOPRESSIN (VP) IN THE TREATMENT OF REFRACTORY SEPTIC SHOCK (1998) (0)
Structure-Metabolic Stability Relationship of Quinoline-Based Phosphodiesterase 5 Inhibitors (2022) (0)
The Inhibition of Gck Affect MAPK Cascade in Multiple Myeloma (2018) (0)
Anti-cocaine catalytic antibody (1999) (0)
A342 ANTI-COCAINE CATALYTIC ANTIBODY PREVENTS LETHALITY FORM COCAINE IN RATS (1997) (0)
Novel Hypoglycemic Dihydropyridones Serendipitously Discovered from O‐ versus C‐Alkylation in the Synthesis of VMAT2 Antagonists. (2009) (0)
Abstract 150: A Phase II Multicenter Randomized Controlled Trial of Tiopronin for Aneurysmal Subarachnoid Hemorrhage (2019) (0)
Ovarian hormones mediate the prophylactic efficacy of (R,S)-ketamine and (2R,6R)-hydroxynorketamine in female mice (2019) (0)
Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells (2020) (0)
N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB (2020) (0)
Silencing c-Myc Translation as a Therapeutic Strategy through Targeting PI 3 K Delta and CK 1 Epsilon in Hematological Malignancies Short title : Targeting PI 3 K and CK 1 in Myc Driven Lymphoma (2016) (0)
HEMODYNAMIC EFFECTS OF VASOPRESSIN IN THE TREATMENT OF VASODILATORY SEPTIC SHOCK (1998) (0)
Process for preparing benzothiazepine from gamma-aminoalkylbenzenes (2009) (0)
Preclinical Biodistribution, Dosimetry and Toxicology of [11C]NOP46 - a potential PET biomarker for chronic pain in humans. (2018) (0)
Using (r) optically pure -tofisopam to treat and prevent anxiety disorders. (1999) (0)
A MICROFLUIDIC AFFINITY APTASENSOR (2007) (0)
Mutants of Cocaine Esterase (2019) (0)
A novel approach to the blood pressure paradox in hemodialysis patients Use of exogenous vasopressin to support pressure during hemodialysis (2003) (0)
Synthesis of C‐3 Alkyl Analogues of Cocaine. (2001) (0)
Synthesis of 1-Thioglycosides. (1996) (0)
Vasopressin in septic shock. (2008) (0)
Development of lnhibitory Ligands (1987) (0)
CONCOMITANT USE OF LOW DOSE VASOPRESSIN AND BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHF AND RELATIVE OLIGURIA: 665 (2004) (0)
Chapter 24 – Alternate Sources of Human Embryonic Stem Cells (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donald W. Landry?

Donald W. Landry is affiliated with the following schools: